These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 26429980)

  • 1. Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade.
    Iams WT; Lovly CM
    Clin Cancer Res; 2015 Oct; 21(19):4270-7. PubMed ID: 26429980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.
    Tognon CE; Sorensen PH
    Expert Opin Ther Targets; 2012 Jan; 16(1):33-48. PubMed ID: 22239439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer.
    Haisa M
    J Int Med Res; 2013 Apr; 41(2):253-64. PubMed ID: 23569026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor.
    Vincent EE; Elder DJ; Curwen J; Kilgour E; Hers I; Tavaré JM
    PLoS One; 2013; 8(6):e66963. PubMed ID: 23826179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
    You L; Liu C; Tang H; Liao Y; Fu S
    Curr Pharm Des; 2014; 20(17):2899-911. PubMed ID: 23944362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy.
    Werner H; Sarfstein R; Bruchim I
    Expert Opin Investig Drugs; 2019 Dec; 28(12):1101-1112. PubMed ID: 31731883
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
    Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor receptor inhibitors: baby or the bathwater?
    Yee D
    J Natl Cancer Inst; 2012 Jul; 104(13):975-81. PubMed ID: 22761272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma.
    Ewing GP; Goff LW
    Clin Colorectal Cancer; 2010 Oct; 9(4):219-23. PubMed ID: 20920993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer.
    De Martino MC; van Koetsveld PM; Feelders RA; de Herder WW; Dogan F; Janssen JAMJL; Hofste Op Bruinink D; Pivonello C; Waaijers AM; Colao A; de Krijger RR; Pivonello R; Hofland LJ
    Endocrine; 2019 Jun; 64(3):673-684. PubMed ID: 30838516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours.
    Browne BC; Eustace AJ; Kennedy S; O'Brien NA; Pedersen K; McDermott MS; Larkin A; Ballot J; Mahgoub T; Sclafani F; Madden S; Kennedy J; Duffy MJ; Crown J; O'Donovan N
    Breast Cancer Res Treat; 2012 Dec; 136(3):717-27. PubMed ID: 23117852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871).
    Pavlicek A; Lira ME; Lee NV; Ching KA; Ye J; Cao J; Garza SJ; Hook KE; Ozeck M; Shi ST; Yuan J; Zheng X; Rejto PA; Kan JL; Christensen JG
    Mol Cancer Ther; 2013 Dec; 12(12):2929-39. PubMed ID: 24107449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
    Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
    Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R.
    de Lint K; Poell JB; Soueidan H; Jastrzebski K; Vidal Rodriguez J; Lieftink C; Wessels LF; Beijersbergen RL
    Mol Cancer Ther; 2016 Jul; 15(7):1545-56. PubMed ID: 27196766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the insulin growth factor receptor 1.
    Arnaldez FI; Helman LJ
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):527-42, vii-viii. PubMed ID: 22520978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer.
    Tao Y; Pinzi V; Bourhis J; Deutsch E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):591-602. PubMed ID: 17898809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
    Ozkan EE
    Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF1R blockade with ganitumab results in systemic effects on the GH-IGF axis in mice.
    Moody G; Beltran PJ; Mitchell P; Cajulis E; Chung YA; Hwang D; Kendall R; Radinsky R; Cohen P; Calzone FJ
    J Endocrinol; 2014 Apr; 221(1):145-55. PubMed ID: 24492468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors.
    Scagliotti GV; Novello S
    Cancer Treat Rev; 2012 Jun; 38(4):292-302. PubMed ID: 21907495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.